Evidence-based leaflet human papillomavirus (HPV) vaccination for pupils
| ISRCTN | ISRCTN86240771 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN86240771 |
| Protocol serial number | N/A |
| Sponsor | University of Hamburg (Germany) |
| Funder | University of Hamburg (Germany) - paid the salary of the PI |
- Submission date
- 31/01/2011
- Registration date
- 25/03/2011
- Last edited
- 30/06/2014
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Anke Steckelberg
Scientific
Scientific
Martin-Luther King Platz 6
Hamburg
20146
Germany
| asteckelberg@uni-hamburg.de |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Double-blind randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | Impact of an evidence-based leaflet on 'risk knowledge' of human papillomavirus (HPV) vaccination in disadvantaged pupils: a randomised controlled trial |
| Study acronym | HPV-Eva |
| Study objectives | Evidence-based patient information leads to better risk knowledge in human papillomavirus (HPV) vaccination compared to standard information. |
| Ethics approval(s) | 1. The Ministry of Education and Culture, 30/10/2009 2. The Ethics Committee in Hamburg, 11/01/2011, ref: PV3344 |
| Health condition(s) or problem(s) studied | Human papillomavirus (HPV) vaccination |
| Intervention | Intervention: evidence-based patient information Control treatment: standard patient information Pupils received either the evidence-based leaflet or the standard one in the beginning of a 1.5 hour session. |
| Intervention type | Drug |
| Phase | Not Applicable |
| Drug / device / biological / vaccine name(s) | Human papillomavirus (HPV) vaccination |
| Primary outcome measure(s) |
Risk-knowledge, measured immediately after the intervention |
| Key secondary outcome measure(s) |
No secondary outcome measures |
| Completion date | 01/05/2010 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Child |
| Sex | Female |
| Target sample size at registration | 94 |
| Key inclusion criteria | Participants were vocational school pupils who were preparing for grade 10 graduation and who were members of the target group for HPV vaccination. |
| Key exclusion criteria | Does not meet inclusion criteria |
| Date of first enrolment | 01/01/2010 |
| Date of final enrolment | 01/05/2010 |
Locations
Countries of recruitment
- Germany
Study participating centre
Martin-Luther King Platz 6
Hamburg
20146
Germany
20146
Germany
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 17/10/2013 | Yes | No | |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
